3D Printing Medical Device Market
The future of the global 3d printing medical device market looks promising with opportunities in the surgical center, pharmaceutical & biotechnology, and academic institution markets. The global 3d printing medical device market is expected to reach an estimated $6.8 million by 2035 from $3.6 million in 2027 with a CAGR of 8.5% from 2027 to 2035. The major drivers for this market are the growing demand for faster medical device production, the increasing adoption of advanced healthcare technologies, and the rising demand for cost-effective treatment solutions.
- Lucintel forecasts that, within the component category, equipment is expected to witness the highest growth over the forecast period due to the rising device customization demand.
- Within the application category, pharmaceutical & biotechnology is expected to witness the highest growth over the forecast period due to the increasing bioprinting drug research.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the expanding healthcare manufacturing and adoption.
Emerging Trends in 3D Printing Medical Device Market
Between 2025 and 2027, the 3d printing medical device market is poised to transition from prototyping to regulated production of patient-specific devices. Lucintel anticipates market growth as hospitals, device manufacturers and labs connect medical imaging data with qualified materials and validated processes and workflows of distributed manufacturing.
- Patient-specific Implants: Hospitals are expanding their range of customized implants to include cranial, orthopedic and dental. There are already over 100 FDA-cleared 3D printed devices. There is potential for further growth as the introduction of anatomy-specific devices and other implants that improve the clinical fit will reduce the need for implant inventory.
- Regulated Digital Manufacturing: Many medical device manufacturers are moving production records and quality assurance to connected systems. The publication of multiple ASTM additive manufacturing standards in 2025 facilitated the repeatability of methods and approaches to qualification. Digital traceability will guide manufacturing decisions because regulators and hospitals require consistent outcomes.
- Advanced Biomaterials: Beyond the traditional use of titanium and cobalt-chromium alloys in the field of biomedical implants, there is a growing interest in the use of polymers such as PEEK, as well as bioactive and resorbable materials. Improving the porosity of implant materials for enhanced bone integration has been a focus of recent research.
- Point-of-care Production: Many large hospitals and academic medical centers are producing surgical guides and models in-house, and plans for 2025-2027 envision 24 hour turnaround times. Localized manufacturing will gain more traction for time-sensitive, customized cases where transport of implants to the site of use is inefficient.
- Automation and Integration of Workflows: Companies will link imaging, simulation, printing, inspection and post-processing with software to automate process validation, making integrated workflows a top priority for 2026 equipment upgrades. Integrated workflows will decrease labor dependence and decrease turnaround times, enabling additive manufacturing for medical devices.
3D printing of medical devices is focused on patient specific implants and production tooling and fixtures. For manufacturing to gain widespread acceptance, there will be a shift from laboratory based devices to safe, effective, and scalable devices. For medical devices, Integrated workflow systems will necessitate combination of automated, validated process and post-processing. Regulatory approved materials and automation will be critical to maintain an edge in the market. Durable value will accrue to integrated companies, while companies lacking clinically integrative systems will continue to experience weak traceability and difficulty gaining reimbursement and market share.
Recent Developments in the 3D Printing Medical Device Market
3D printing medical devices is transitioning from unique, one-off prototypes to repeatable, regulated production. 2025-2027 will be a growing period for this sector as hospitals request patient-specific implants, device manufacturers automate and validate the production process, and software integrates image processing and device fabrication. Lucintel anticipates growth beyond the current dental applications. However, issues related to reimbursement, clinical evidence, and quality systems will determine which companies gain a competitive edge in this space.
- Manufacturing Expansion: In January 2025, Formlabs expanded its medical manufacturing portfolio with the introduction of the Form 4B ecosystem. Form 4B supports production speeds of up to 100 mm per hour and is expected to reduce the costs associated with fabricating medical devices. This will make it economically feasible for hospitals and research laboratories to manufacture medical devices on-site.
- Technology Introduction: In March 2025, 3D Systems announced improvements to its VSP surgical planning platform. The expanded platform digitizes workflows across multiple surgical procedures. As digital workflows across imaging, surgical planning, and printing improve, the tendency to purchase standalone 3D printers will decrease.
- May 2025: Furthering their strategic collaboration from the previous year, Materialise and Siemens Healthineers strengthened the interoperability of their software to establish more seamless medical-image-processing and additive-manufacturing workflows. The focus now shifts to the development of interoperable connections. Shorter planning cycles for interoperability are likely to encourage larger health systems to adopt standardized departmental 3D printing across the enterprise.
- July 2025: The U.S. Food and Drug Administration (FDA) granted a special 510(k) clearance to a 3D-printed patient-specific orthopedic device, permitting a manufacturing-related tolerance of 0.1 millimeter. While such tolerances have been allowed in the past, the recent approval strengthens the FDA's precedent for permitting customized orthopedic implants and increases the level of evidence required to be submitted.
- October 2025: A U.S. hospital network awarded a contract for 12 additive-manufacturing systems to create surgical plans and guides. The multi-site contract signals a change from isolated innovative projects to enterprise-wide deployment, creating continuous and growing demand for related products and services.
During the next three to five years, the growth in additive manufacturing for 3D-printed orthopedic and surgical devices is expected to outpace the overall market volume. Increasing repeatable applications and selective capital spending should fuel the growth. Companies with attractive technology and service capacity should benefit the most; those without regulatory discipline will lose market share.
Strategic Growth Opportunities in the 3D Printing Medical Device Market
The medical devices market based on 3D printing is developing rapidly and transitioning from prototyping toward patient-specific manufacturing. Between 2024 and 2026, the combination of constraints in hospital capacity, shorter surgical pathways, and wider acceptance of the regulation is expected to create commercial opportunities. Lucintel has identified that the main sources of revenue from the 3D printing industry will shift from the sale of printers to the sale of validated materials, software, and clinical workflows, as well as subscription-based services.
- Patient-specific Implants: Cranial and spinal implants, as well as other implantable medical devices, have the potential to significantly reduce the need for inventory by providing a better anatomical fit. The U.S. Food and Drug Administration (FDA) cleared more than 100 3D-printed medical devices during the first quarter of 2025. Demand for patient-specific implants, coupled with the development of standardized and digital design-to-production workflows, creates a significant opportunity for implantable medical devices.
- Dental Production: The dental industry has an increasing need for high-volume production of aligners, dentures, and surgical guides, among other dental devices. In February 2025, Form labs reported that its Dental Business Unit served more than 50,000 professionals across the world. The development of automation in the manufacturing of dental devices will cause a shift toward localized, subscription-based manufacturing.
- Hospital-based Manufacturing: Anatomical models and guides, as well as low-risk medical devices, can be manufactured close to the point-of-care. In March 2025, the Mayo Clinic reported more than 20 specialties using 3D printing.
- Biocompatible Premium Materials: While currently used in low-volume, high-complexity applications, medical devices manufactured with advanced 3D printing technologies, such as EOS, offer the potential for significant growth. In April 2025, EOS announced more than 1,000 of its metal systems installed worldwide. Long-term evidence will be crucial to gain the confidence of medical device manufacturers.
- Regulated Digital Manufacturing: Software that manages design history and device traceability can be sold as a subscription. The FDA's device database listed more than 6,000 product codes in May 2025. Manufacturers will switch to systems that enable them to create production records that are compliant with industry standards, since auditing record-keeping across multiple facilities remains a challenge.
Demand will increasingly reward suppliers that combine clinical data with reliable production data. The best positions will integrate regulated materials, software, and services. Hospital and device company customers will buy fewer standalone machines and more validated outcomes. That should reward manufacturers that can support design, certification, and manufacturing as well as provide post-market data.
3D Printing Medical Device Market Drivers and Challenges
The 3d printing medical device market is anticipated to experience rapid growth during the forecast period, 2017-2027, due to the rapid advancements in technology, and emerging trends in the medical field, and healthcare reimbursement. While opportunities abound for 3D-printed medical devices because of advancements in digital workflows and production, and an increasing focus on patient-centric treatment, the barriers to entry in this market will continue to include validation, material, reimbursement, and production costs. Other trends impacting this market include decentralized manufacturing and increasing emphasis on healthcare sustainability. Lucintel expects these trends to continue over the next few years.
The major factors driving the 3d printing medical device market will be:
- Patient-specific Customization: Personalized implants and prosthetics require a significantly higher degree of anatomical precision compared to surgical guides, which are used to transfer anatomy, position, and orientation to a surgical site. Adding patient-specific 3D anatomical models to the surgeon's toolkit improved procedure planning for complex cases by approximately 20% as of March 2025. In the near-term, increasing patient-specific requests for surgical devices is expected to create a greater demand for the customization of implants and prosthetics.
- Technology Enhancements: Enhancements in additive manufacturing systems and integration with AI and other digital technologies are enhancing printing, design, and post-processing. As of June 2025, a number of medical-focused additive manufacturing systems claimed the capability of supporting parts with dimensional tolerances of less than 100 microns for select applications. Functional integration and highly complex geometries will drive enhancements in the field of 3D printing for medical devices in the near-term.
- Regulatory Support and Clinical Validation: Manufacturers of medical devices, including 3D printed devices, are waiting on clearer regulatory pathways and clinical validation. During 2025, ongoing efforts by standards and regulatory agencies to ensure harmonization and consistency of requirements for medical software, biocompatibility, and additive manufacturing process control, expanded. It is expected that during the next three to five years, consistent and harmonized requirements will reduce uncertainty and increase opportunities for market investments. The availability of strong clinical studies will aid the move of 3D printed devices to routine clinical use.
- Sustainability and Waste Reduction: The use of additive manufacturing may reduce the amount of material wasted in a manufactured product, especially when only small amounts of material are needed in certain areas of the product. In 2025, some health care product manufacturers reported the potential to save 30% of the material used in low volume product components, by designing the components using additive manufacturing. Sustainability and waste reduction are becoming increasingly important and will impact product design. It is expected that in the custom, low volume products, the use of additive manufacturing to decrease scrap and increase sustainability will be significant.
- Improved Manufacturing and Cost Savings: Additive manufacturing has the potential to reduce the time required to manufacture certain products, such as medical instruments and devices. In 2026, the use of automated additive manufacturing processes for select surgical products, reduced the time required to manufacture the products by 25%. This process, along with lower tooling costs, is expected to aid in the commercial availability of specialized, and customized medical devices and products.
The challenges facing this market include:
- Regulatory and Quality Compliance Complexity: Different types of medical devices have unique and stringent requirements on safety, repetitiveness, sterilization and traceability, performance, and longevity. In February 2025, devices manufactured by patient specific processes often required multiple validation steps before clinical use. This extended the timeline for the development of the devices to more than one year. Different processes and change controls can extend regulatory approval times and increase costs. It will be important to standardize digital records and adopt validated materials, and design and implement robust quality systems.
- Limitation of Materials and Performance: The types of materials used in implantable devices are less than the materials used in conventional manufacturing. In July 2025, most medical additive manufacturing systems used less than ten families of implant grade materials. In the next three to five years, this may constrain applications requiring devices with high fatigue resistance, and longevity and biological functions. Research into bioresorbable, antimicrobial, and multi-material systems may be vital.
- High Costs: Uncertainty with reimbursement, and workforce shortages": The cost of advanced printers, certified materials, and software, as well as the maintenance and personnel required to run them, creates a significant financial barrier. Additionally, reimbursement policies may not account for the cost of customized devices. Assessments during the 2025 implementation indicated that the cost of equipment and validation for small facilities would exceed traditional tooling costs by more than 20%, and smaller hospitals may be slow to adopt the technology. Access to the market would improve with greater training, service bureaus, shared facilities, and clear reimbursement policies.
With rapid development in digital design and automation, the 3d printing medical device market is expanding, and localized manufacturing is enabling broader distribution and reducing the carbon footprint of devices. Developments and clarification of regulations will promote broader use of medical devices, implants, prosthetics, and surgical tools as well as 3D printing of anatomical models. Restrictive constraints, such as material costs, compliance, and reimbursement, and lack of trained personnel, may restrict the market. Initial success in this space will depend on validated workflows, clinical evidence, and software, as well as collaboration among manufacturers, health care and research institutions.
List of 3D Printing Medical Device Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies 3d printing medical device market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3d printing medical device market companies profiled in this report include-
- 3D Systems Corporation
- Stratasys
- GE Healthcare
- Materialise NV
- Renishaw
3D Printing Medical Device Market by Segment
The study includes a forecast for the global 3d printing medical device market by component, technology, application, end use, and region.
3D Printing Medical Device Market by Component [Value ($M) from 2019 to 2035]:
- Equipment
- Materials
- Plastics
- Ceramic
- Metal
- Software & Services
- Others
3D Printing Medical Device Market by Technology [Value ($M) from 2019 to 2035]:
- Laser Beam Melting
- Photo Polymerization
- Electron Beam Melting
- Droplet Deposition
- Three-Dimensional Printing (3DP)
3D Printing Medical Device Market by Application [Value ($M) from 2019 to 2035]:
- Surgical Guides
- Surgical Instruments
- Prosthetics & Implants
- Tissue Engineering Products
- Others
3D Printing Medical Device Market by End Use [Value ($M) from 2019 to 2035]:
- Surgical Centers
- Pharmaceutical & Biotechnology
- Academic Institutions
3D Printing Medical Device Market by Region [Value ($M) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the 3D Printing Medical Device Market
The 3d printing medical device market is evolving from prototyping to regulated, patient-specific production. During 2025-2027, approvals, hospital manufacturing partnerships, and local supply chains will shape market adoption. The ability of regulatory agencies to keep up and production at scale will determine the first commercial deployments, according to Lucintel.
- United States: Advancements in regulatory framework and hospital-based manufacturing continue; in January 2025, the FDA issued updated additive-manufacturing guidance, which strengthened the agency's position on process and material controls and software validity. In the next three to five years, the guidance may facilitate custom-made implants, surgical guides, and other dental-related devices.
- China: Continued governmental support of advanced manufacturing, including medical devices, will aid local manufacturing; in March 2025, the National Medical Products Administration (NMPA) kept in place special review processes for advanced and innovative medical devices, including those made using additive manufacturing. This may accelerate local orthopedic and dental device production.
- Germany: Industrial suppliers are developing regulated production capabilities. EOS reported operating more than 60,000 industrial systems worldwide, as of May 2025. German OEMs continued integrating validated metal-printing workflows for implants. This matters because German engineering and certification expertise can support repeatable European production.
- India: Local manufacturing of medical devices, and public healthcare initiatives, continue to encourage the local manufacture of medical devices; in Feb 2025, the Department of Pharmaceuticals further implemented the Production-Linked Incentive (PLI) scheme for medical devices. Over the years, the PLI scheme has been extended to cover multiple categories of medical devices. This has created and increased domestic production capacity of implants, prosthetics and other medical devices, thereby decreasing dependence on imports.
- Japan: Several Japanese companies are investing in partnerships integrating clinical practices with advanced manufacturing; in April 2025, Nikon's additive-manufacturing business continued advancing commercialization of metal systems that incorporate multilaser production, including configurations using four lasers. This development supports broader adoption of customized orthopedic and dental devices.
Features of the Global 3D Printing Medical Device Market
- Market Size Estimates: 3d printing medical device market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: 3d printing medical device market size by various segments, such as by component, technology, application, end use, and region in terms of value ($M).
- Regional Analysis: 3d printing medical device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different component, technology, application, end use, and regions for the 3d printing medical device market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3d printing medical device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the 3d printing medical device market by component (equipment, materials, plastics, ceramic, metal, software & services, and others), technology (laser beam melting, photo polymerization, electron beam melting, droplet deposition, and three-dimensional printing (3DP)), application (surgical guides, surgical instruments, prosthetics & implants, tissue engineering products, and others), end use (surgical centers, pharmaceutical & biotechnology, and academic institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?